Co-Authors
This is a "connection" page, showing publications co-authored by MARK T BEDFORD and YUE LU.
Connection Strength
0.871
-
The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer. Nat Commun. 2023 01 23; 14(1):363.
Score: 0.219
-
Mouse Models of Overexpression Reveal Distinct Oncogenic Roles for Different Type I Protein Arginine Methyltransferases. Cancer Res. 2019 01 01; 79(1):21-32.
Score: 0.163
-
Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation. Mol Cell. 2014 Feb 06; 53(3):484-97.
Score: 0.117
-
TDRD3 is an effector molecule for arginine-methylated histone marks. Mol Cell. 2010 Dec 22; 40(6):1016-23.
Score: 0.095
-
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors. J Immunother Cancer. 2024 Sep 23; 12(9).
Score: 0.061
-
Methyl-lysine readers PHF20 and PHF20L1 define two distinct?gene expression-regulating NSL complexes. J Biol Chem. 2022 03; 298(3):101588.
Score: 0.051
-
CARM1 inhibition reduces histone acetyltransferase activity causing synthetic lethality in CREBBP/EP300-mutated lymphomas. Leukemia. 2020 12; 34(12):3269-3285.
Score: 0.046
-
CARM1 methylates MED12 to regulate its RNA-binding ability. Life Sci Alliance. 2018 Oct; 1(5):e201800117.
Score: 0.040
-
Deficient LRRC8A-dependent volume-regulated anion channel activity is associated with male infertility in mice. JCI Insight. 2018 08 23; 3(16).
Score: 0.040
-
The arginine methyltransferase CARM1 represses p300?ACT?CREMt activity and is required for spermiogenesis. Nucleic Acids Res. 2018 05 18; 46(9):4327-4343.
Score: 0.039